Is being a morning person in your DNA?

February 02, 2016

23andMe, Inc., the leading personal genetics company, today announced the results of one of the largest genome-wide association studies of its kind, identifying genetic variants associated with being a morning person.

Published in Nature Communications the study identified 15 locations in DNA (loci) associated with "morningness."

"In this study we set out to discover more about an individual's preference toward early rising and were able to identify the genetic associations with "morningness" as well as ties to lifestyle patterns and other traits," said Youna Hu, PhD, who led 23andMe's research on the paper. "This type of study speaks to the power of the 23andMe database, which can yield genetic insights into a variety of conditions and traits, and potentially how those genetic factors are affected by behavior and environment."

Morningness is governed by differences in circadian rhythm, which have previously been linked to medically relevant traits such as sleep, obesity and depression. The study of more than 89,000 23andMe customers who consented to participate in research* found that seven of the loci associated with morningness are near genes previously known to be involved in circadian rhythm, including HCRTR2 (linked to narcolepsy), FBXL3 (shown to have extended circadian period) and VIP (found to prolong REM sleep). Additional findings from the study and data from 23andMe customers include: The researchers also found that after taking into account the effect of age and sex, morning persons are likely to have lower BMI. While this does not imply a causation, some of the findings may warrant a deeper dive into the biology. For instance, variants in the FTO gene associated with obesity were also found to be associated with being a morning person.

"The beauty of 23andMe is the ability to conduct research on common traits like being a lark or a night owl, which affect everyone, yet typically wouldn't receive funding for a study," said David Hinds, Ph.D., senior research scientist at 23andMe and a co-author of the paper. "With the information we have, we can uncover the genetics behind a variety of conditions and diseases, and hopefully reach a better understanding of how we differ from one another."

The findings also reinforce the current understanding of circadian biology and may guide future studies of circadian rhythms, sleep and related disorders.

The full study manuscript is available in Nature Communications, and a graphic outlining the findings is available at 23andMe blog
-end-
About 23andMe

23andMe, Inc. is the leading personal genetics company. Founded in 2006, the mission of the company is to help people access, understand and benefit from the human genome. 23andMe has over one million customers worldwide with over 80 percent consented to participate in research. 23andMe, Inc. is located in Mountain View, CA. More information is available at http://www.23andMe.com.

*Data was contributed by 23andMe customers who provided informed consent to take part in this research under a protocol approved by the AAHRPP-accredited institutional review board, Ethical and Independent Review Services.

23andMe, Inc.

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.